- Home
- X vs QGEN Comparison
X vs QGEN Comparison
Compare X & QGEN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- X
- QGEN
- Stock Information
- Founded
- X 1901
- QGEN 1986
- Country
- X United States
- QGEN Netherlands
- Employees
- X N/A
- QGEN N/A
- Industry
- X Steel/Iron Ore
- QGEN Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- X Industrials
- QGEN Health Care
- Exchange
- X Nasdaq
- QGEN Nasdaq
- Market Cap
- X 9.2B
- QGEN 9.1B
- IPO Year
- X N/A
- QGEN 1996
- Fundamental
- Price
- X $42.45
- QGEN $41.86
- Analyst Decision
- X Buy
- QGEN Buy
- Analyst Count
- X 5
- QGEN 8
- Target Price
- X $39.91
- QGEN $50.53
- AVG Volume (30 Days)
- X 4.8M
- QGEN 1.3M
- Earning Date
- X 05-01-2025
- QGEN 05-07-2025
- Dividend Yield
- X 0.47%
- QGEN 3.15%
- EPS Growth
- X N/A
- QGEN N/A
- EPS
- X 0.43
- QGEN 0.42
- Revenue
- X $15,207,000,000.00
- QGEN $2,002,874,000.00
- Revenue This Year
- X $9.41
- QGEN $4.89
- Revenue Next Year
- X $3.15
- QGEN $6.41
- P/E Ratio
- X $98.44
- QGEN $100.26
- Revenue Growth
- X N/A
- QGEN 3.31
- 52 Week Low
- X $26.92
- QGEN $37.63
- 52 Week High
- X $46.18
- QGEN $47.93
- Technical
- Relative Strength Index (RSI)
- X 52.06
- QGEN 50.87
- Support Level
- X $40.41
- QGEN $42.04
- Resistance Level
- X $44.71
- QGEN $43.46
- Average True Range (ATR)
- X 1.31
- QGEN 0.83
- MACD
- X -0.19
- QGEN -0.10
- Stochastic Oscillator
- X 57.52
- QGEN 17.95
About X United States Steel Corporation
United States Steel Corp operates primarily in the United States but also has a steelmaking capacity in Slovakia. The company's operating segments include North American Flat-Rolled (Flat-Rolled), Mini Mill, U. S. Steel Europe (USSE), and Tubular Products (Tubular). The Flat-Rolled segment includes U. S. Steel's integrated steel plants and equity investees in North America involved in the production of slabs, strip mill plates, sheets, and tin mill products, as well as all iron ore and coke production facilities in the United States. It primarily serves North American customers in the service center, conversion, transportation, construction, container, and appliance, and electrical markets.
About QGEN Qiagen N.V.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2023 sales), followed by EMEA (32%), and the Asia-Pacific (16%).